Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044201105> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2044201105 endingPage "A196" @default.
- W2044201105 startingPage "A196.1" @default.
- W2044201105 abstract "<h3>Background</h3> GM1 gangliosidosis, a rare metabolic disease, is an autosomal recessive lysosomal storage disorder caused by a deficiency of beta-galactosidase, and characterised by the generalised accumulation of GM1 ganglioside. The most severe form, called type I or early infantile, progressively destroys the neurons and the cells of the spinal cord. No pharmacological treatment is available at present and children affected by GM1 type I usually do not survive past the age of three. Miglustat (N-butyldeoxynojirimycin) is an iminosugar and functions as a competitive and reversible inhibitor of glucosylceramide synthase, the initial enzyme in reactions resulting in the synthesis of most glycosphingolipids. It is indicated in lysosomal storage diseases and it had positive results in GM2 gangliosidosis. <h3>Purpose</h3> To describe our experience in the 12-month treatment with an individual formulation of miglustat, for a patient affected by GM1 gangliosidosis. <h3>Materials and Methods</h3> In July 2011 Regione-Marche Centre for Rare Diseases involved our Hospital Pharmacy (authorization, galenic compounding) in supplying miglustat for an 18-month-old child with type I GM1 gangliosidosis, who was clearly showing severe signs of the pathology, lacking any other therapy. Miglustat is off-label for this indication, so the approval of the Ethics Committee was necessary with the duty to report results every three months. Personalized capsules were prepared for the hospital and home administration, with different doses (from 30 mg/d to 210 mg/d in 3 doses). The capsules were prepared from Zavesca, exclusively using mannitol as excipient: lactose is to be avoided in GM1 gangliosidosis <h3>Results</h3> Miglustat provided surprising results, but only in the first four weeks of treatment. Frequent infections and seizures, typical of the disease, occurred later. <h3>Conclusions</h3> The treatment is still being used, but after 12 months, we are considering stopping it. It would be important to compare other experiences in order to better evaluate the effectiveness of the treatment. No conflict of interest." @default.
- W2044201105 created "2016-06-24" @default.
- W2044201105 creator A5002989790 @default.
- W2044201105 creator A5006057073 @default.
- W2044201105 creator A5011473638 @default.
- W2044201105 creator A5025702193 @default.
- W2044201105 creator A5037692750 @default.
- W2044201105 creator A5049763605 @default.
- W2044201105 creator A5050968935 @default.
- W2044201105 creator A5060113669 @default.
- W2044201105 creator A5068506206 @default.
- W2044201105 creator A5074727457 @default.
- W2044201105 creator A5079362381 @default.
- W2044201105 creator A5090890338 @default.
- W2044201105 date "2013-03-01" @default.
- W2044201105 modified "2023-10-16" @default.
- W2044201105 title "CPC-086 Miglustat Off-Label in a Paediatric Formulation For a Rare Metabolic Disease: Early Infantile GM1 Gangliosidosis" @default.
- W2044201105 doi "https://doi.org/10.1136/ejhpharm-2013-000276.543" @default.
- W2044201105 hasPublicationYear "2013" @default.
- W2044201105 type Work @default.
- W2044201105 sameAs 2044201105 @default.
- W2044201105 citedByCount "2" @default.
- W2044201105 countsByYear W20442011052013 @default.
- W2044201105 countsByYear W20442011052020 @default.
- W2044201105 crossrefType "journal-article" @default.
- W2044201105 hasAuthorship W2044201105A5002989790 @default.
- W2044201105 hasAuthorship W2044201105A5006057073 @default.
- W2044201105 hasAuthorship W2044201105A5011473638 @default.
- W2044201105 hasAuthorship W2044201105A5025702193 @default.
- W2044201105 hasAuthorship W2044201105A5037692750 @default.
- W2044201105 hasAuthorship W2044201105A5049763605 @default.
- W2044201105 hasAuthorship W2044201105A5050968935 @default.
- W2044201105 hasAuthorship W2044201105A5060113669 @default.
- W2044201105 hasAuthorship W2044201105A5068506206 @default.
- W2044201105 hasAuthorship W2044201105A5074727457 @default.
- W2044201105 hasAuthorship W2044201105A5079362381 @default.
- W2044201105 hasAuthorship W2044201105A5090890338 @default.
- W2044201105 hasBestOaLocation W20442011051 @default.
- W2044201105 hasConcept C118552586 @default.
- W2044201105 hasConcept C126322002 @default.
- W2044201105 hasConcept C187212893 @default.
- W2044201105 hasConcept C21850170 @default.
- W2044201105 hasConcept C2777332695 @default.
- W2044201105 hasConcept C2777878887 @default.
- W2044201105 hasConcept C2778098279 @default.
- W2044201105 hasConcept C2778186239 @default.
- W2044201105 hasConcept C2778264360 @default.
- W2044201105 hasConcept C2779134260 @default.
- W2044201105 hasConcept C2779390119 @default.
- W2044201105 hasConcept C2779969927 @default.
- W2044201105 hasConcept C71924100 @default.
- W2044201105 hasConcept C98274493 @default.
- W2044201105 hasConceptScore W2044201105C118552586 @default.
- W2044201105 hasConceptScore W2044201105C126322002 @default.
- W2044201105 hasConceptScore W2044201105C187212893 @default.
- W2044201105 hasConceptScore W2044201105C21850170 @default.
- W2044201105 hasConceptScore W2044201105C2777332695 @default.
- W2044201105 hasConceptScore W2044201105C2777878887 @default.
- W2044201105 hasConceptScore W2044201105C2778098279 @default.
- W2044201105 hasConceptScore W2044201105C2778186239 @default.
- W2044201105 hasConceptScore W2044201105C2778264360 @default.
- W2044201105 hasConceptScore W2044201105C2779134260 @default.
- W2044201105 hasConceptScore W2044201105C2779390119 @default.
- W2044201105 hasConceptScore W2044201105C2779969927 @default.
- W2044201105 hasConceptScore W2044201105C71924100 @default.
- W2044201105 hasConceptScore W2044201105C98274493 @default.
- W2044201105 hasIssue "Suppl 1" @default.
- W2044201105 hasLocation W20442011051 @default.
- W2044201105 hasOpenAccess W2044201105 @default.
- W2044201105 hasPrimaryLocation W20442011051 @default.
- W2044201105 hasRelatedWork W1607228965 @default.
- W2044201105 hasRelatedWork W2043774580 @default.
- W2044201105 hasRelatedWork W2044201105 @default.
- W2044201105 hasRelatedWork W2059320901 @default.
- W2044201105 hasRelatedWork W2076853017 @default.
- W2044201105 hasRelatedWork W2090051116 @default.
- W2044201105 hasRelatedWork W2103304553 @default.
- W2044201105 hasRelatedWork W2513137839 @default.
- W2044201105 hasRelatedWork W2525933295 @default.
- W2044201105 hasRelatedWork W2795823005 @default.
- W2044201105 hasVolume "20" @default.
- W2044201105 isParatext "false" @default.
- W2044201105 isRetracted "false" @default.
- W2044201105 magId "2044201105" @default.
- W2044201105 workType "article" @default.